King's College London

Research portal

Expert review of clinical pharmacology, ‎1751-2433

Journal

  1. UK Medical Cannabis Registry: an analysis of clinical outcomes of medicinal cannabis therapy for generalized anxiety disorder

    Ergisi, M., Erridge, S., Harris, M., Kawka, M., Nimalan, D., Salazar, O., Loupasaki, K., Ali, R., Holvey, C., Coomber, R., Platt, M., Rucker, J. J. & Sodergren, M. H., 18 Jan 2022, (E-pub ahead of print) In: Expert review of clinical pharmacology. 9 p.

    Research output: Contribution to journalArticlepeer-review

  2. UK Medical Cannabis Registry: an analysis of clinical outcomes of medicinal cannabis therapy for chronic pain conditions

    Harris, M., Erridge, S., Ergisi, M., Nimalan, D., Kawka, M., Salazar, O., Ali, R., Loupasaki, K., Holvey, C., Coomber, R., Usmani, A., Sajad, M., Rucker, J. J., Platt, M. & Sodergren, M. H., 23 Dec 2021, (E-pub ahead of print) In: Expert review of clinical pharmacology. 13 p.

    Research output: Contribution to journalArticlepeer-review

  3. Pediatric pharmacokinetics of the antibiotics in the access and watch groups of the 2019 WHO model list of essential medicines for children: a systematic review

    Rashed, A. N., Jackson, C., Gastine, S., Hsia, Y., Bielicki, J. A., Standing, J. F., Tomlin, S. & Sharland, M., 2 Dec 2019, In: Expert review of clinical pharmacology. 12, 12, p. 1099-1106 8 p.

    Research output: Contribution to journalArticlepeer-review

  4. GAPPS (Grading and Assessment of Pharmacokinetic-Pharmacodynamic Studies) a critical appraisal system for antimicrobial PKPD studies–development and application in pediatric antibiotic studies

    Gastine, S., Rashed, A. N., Hsia, Y., Jackson, C., Barker, C. I. S., Mathur, S., Tomlin, S., Lutsar, I., Bielicki, J., Standing, J. F. & Sharland, M., 2019, In: Expert review of clinical pharmacology. 12, 12, p. 1091-1098 8 p.

    Research output: Contribution to journalReview articlepeer-review

  5. Pharmacological management of diabetes in severe mental illness: a comprehensive clinical review of efficacy, safety and tolerability

    Lally, J., O’ Loughlin, A., Stubbs, B., Guerandel, A., O’Shea, D. & Gaughran, F., 9 Mar 2018, (E-pub ahead of print) In: Expert review of clinical pharmacology. 11, 4, p. 411-424 14 p.

    Research output: Contribution to journalReview articlepeer-review

  6. Psychopharmacological advances in eating disorders

    Himmerich, H. & Treasure, J., 2018, In: Expert review of clinical pharmacology. 11, 1, p. 95-108

    Research output: Contribution to journalArticlepeer-review

  7. Novel pharmaceuticals in the treatment of psychosis in Parkinson's disease.

    Broadstock, M., Ballard, C. G. & Corbett, A. M. J., 28 Mar 2014, In: Expert review of clinical pharmacology. 7, 6, p. 779-786 8 p.

    Research output: Contribution to journalArticlepeer-review

  8. Efficacy and mechanism of anticonvulsant drugs in migraine

    Hoffmann, J., Akerman, S. & Goadsby, P. J., 1 Mar 2014, In: Expert review of clinical pharmacology. 7, 2, p. 191-201 11 p.

    Research output: Contribution to journalReview articlepeer-review

  9. Attrition in the drug discovery process: lessons to be learned from the safety pharmacology paradigm

    Curtis, M. J. & Pugsley, M. K., Mar 2012, In: Expert review of clinical pharmacology. 5, 3, p. 237-240 4 p.

    Research output: Contribution to journalEditorialpeer-review

  10. Recent advances in bipolar disorder pharmacotherapy: focus on bipolar depression and rapid cycling

    Datta, V. & Cleare, A. J., 2009, In: Expert review of clinical pharmacology. 2, 4, p. 423-34 12 p.

    Research output: Contribution to journalArticlepeer-review

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454